Enovid - SaNOtize NONS Nitric Oxide Nasal Spray 3 Pack
About the Product
Enovid provides a daily protective measure against viruses and can be used also after a potential exposure to viruses. It helps in fighting a broad spectrum of viruses, including the coronavirus SARS-CoV-2 (read more).
It reduces SARS-CoV-2 viral load by more than 95% within 24 hours and by more than 99% in 72 hours (UK study)
Enovid is the brand name for SaNOtize nasal spray. The product is also known as SaNOtize NONS which stands for Nitric Oxide Nasal Spray. In some countries, Enovid is sold under the brand name Virx.
ENOVID is approved as a nasal spray device in Israel with registration number 34390001 and with the following indication for use: "ENOVID is a nasal spray device intended for use as a proactive mechanical and chemical barrier against viruses within the nasal cavity."
How it Works
SaNOtize NONS is a nitric oxide nasal spray that releases a small dose of nitric oxide and is designed to kill viruses in the upper airways. This prevents them from incubating and spreading to the lungs by providing a physical and chemical barrier. It doesn’t just block viruses, but actually kills them.
Enovid was scientifically tested and proven to kill 99.9% of viruses within 2 minutes (lab test conducted by researchers from Utah State University, 99.9% of SARS-CoV-2 in a petri dish were killed within two minutes)
Nitric Oxide is known for its antimicrobial qualities and SaNOtize's product offers a practical way to deliver it as a liquid, while the Nitric Oxide is formed only upon administration when all liquid ingredients are mixed.
Affected Viruses
Enovid has been shown to be effective in the lab against a wide range of viruses and new variants of the SARS-CoV-2 won’t interfere with its effectiveness. SaNOtize says “It contains a broad-spectrum antiviral which kills all viruses and all variants.” [published on The Times of Israel, 22/03/21]
SaNOtize NONS was also shown to reduce SARS-CoV-2 viral load in a UK clinical trial (Phase II): "Patients with a self-administered nasal spray application found to have reduced SARS-CoV-2 log viral load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 72 hours" [published on BusinessWire.com March 2021].
How to Use for Daily Protection
Apply 2-3 times daily (2 sprays per nostril during each use), before and after suspected exposure to viruses in high-risk environments (public transportation, days cares, health care settings, shopping centers, sports events, etc.).
How to Use After Potential Exposure
After a potential exposure – use up to 6 times per day (2 sprays per nostril during each use)
Each sprayer contains 25ml, around 200 doses of spray (about a month's supply)
Ingredients
Sodium chloride, Citric acid, HPMC, Sodium nitrite, Benzalkonium Chloride (the nitric oxide is formed during spraying).
All components are used widely in the food industry and have a very strong safety profile.
Do not use this product if you are sensitive to any of the ingredients
Expiration date: January, 2026
Discard sprayer at the earlier of the expiration date or 60 days after the first opening
Who can use: Adults and children older than 12 years of age.
Contraindications: Children under age 12 years, or if you are pregnant or breast-feeding - consult a physician
If you are sensitive to any of the ingredients, do not use this product!
Storage: Store at room temperature. Do not freeze.
Do not share sprayer with other people to avoid transmission of viruses or germs from person to person
ENOVID can be used after other nasal products
ENOVID is not a drug or a medicine. It does not cause drowsiness
